Michael Klichinsky
Chief Scientific Officer · Carisma Therapeutics Inc.
IndividualSelling only
- 2025
- Oct 7, 2025
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Michael Klichinsky's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- ILLUMINA, INC. - $79.85M in GRAL purchases and sales in the last 12 months
- Darren M. Black - $77.56M in LFST purchases and sales in the last 12 months
- Noubar Afeyan - $75.00M in GENB purchases and sales in the last 12 months
- Andrew J. Mills - $75.00M in MDLN purchases and sales in the last 12 months
- Charles N. Mills - $74.80M in MDLN purchases and sales in the last 12 months
- Keith A. Meister - $74.03M in WGS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Michael Klichinsky?
Michael Klichinsky is a corporate insider, tracked as Chief Scientific Officer of Carisma Therapeutics Inc. (CARM). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Michael Klichinsky last file a Form 4?
The most recent primary Form 4 on record is dated 7 October 2025, one of 2 filings going back to 2025.
Has Michael Klichinsky been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($139K) across all tracked filings.
